Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Decreases Holdings in CVS Health (CVS)

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lessened its holdings in CVS Health (NYSE:CVS) by 2.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 450,209 shares of the pharmacy operator’s stock after selling 11,893 shares during the quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in CVS Health were worth $32,640,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Toronto Dominion Bank boosted its holdings in shares of CVS Health by 3.6% during the fourth quarter. Toronto Dominion Bank now owns 477,273 shares of the pharmacy operator’s stock valued at $34,601,000 after acquiring an additional 16,658 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of CVS Health by 149.8% during the fourth quarter. The Manufacturers Life Insurance Company now owns 4,818,244 shares of the pharmacy operator’s stock valued at $349,322,000 after acquiring an additional 2,889,561 shares during the period. First Trust Advisors LP boosted its holdings in shares of CVS Health by 8.2% during the fourth quarter. First Trust Advisors LP now owns 781,845 shares of the pharmacy operator’s stock valued at $56,684,000 after acquiring an additional 59,251 shares during the period. ACG Wealth boosted its holdings in shares of CVS Health by 22.1% during the fourth quarter. ACG Wealth now owns 9,530 shares of the pharmacy operator’s stock valued at $691,000 after acquiring an additional 1,727 shares during the period. Finally, Greenleaf Trust boosted its holdings in shares of CVS Health by 89.2% during the fourth quarter. Greenleaf Trust now owns 8,502 shares of the pharmacy operator’s stock valued at $616,000 after acquiring an additional 4,008 shares during the period. 83.97% of the stock is owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

Shares of CVS Health stock opened at $63.38 on Friday. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59. CVS Health has a 52 week low of $60.14 and a 52 week high of $84.00. The stock has a market capitalization of $65,599.64, a price-to-earnings ratio of 10.74, a price-to-earnings-growth ratio of 1.07 and a beta of 1.05.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the consensus estimate of $1.88 by $0.04. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. During the same period in the previous year, the business earned $1.71 earnings per share. CVS Health’s revenue for the quarter was up 5.3% compared to the same quarter last year. analysts predict that CVS Health will post 6.33 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 3rd. Shareholders of record on Monday, April 23rd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 3.16%. The ex-dividend date of this dividend is Friday, April 20th. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.

In other CVS Health news, EVP Helena Foulkes sold 19,965 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total value of $1,418,313.60. Following the sale, the executive vice president now directly owns 65,072 shares in the company, valued at $4,622,714.88. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.61% of the stock is currently owned by insiders.

Several equities analysts have recently issued reports on CVS shares. Mizuho set a $95.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Wednesday, January 24th. SunTrust Banks lifted their price objective on shares of CVS Health to $90.00 and gave the company a “buy” rating in a research note on Friday, January 5th. Needham & Company LLC lifted their price objective on shares of CVS Health from $85.00 to $88.00 and gave the company a “buy” rating in a research note on Tuesday, January 2nd. Tigress Financial restated a “buy” rating on shares of CVS Health in a research note on Tuesday, December 26th. Finally, Royal Bank of Canada set a $89.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research note on Thursday, February 8th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. CVS Health currently has a consensus rating of “Buy” and an average target price of $86.81.

TRADEMARK VIOLATION NOTICE: “Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Decreases Holdings in CVS Health (CVS)” was reported by Ticker Report and is the property of of Ticker Report. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3340439/loring-wolcott-coolidge-fiduciary-advisors-llp-ma-decreases-holdings-in-cvs-health-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Etheroll  Trading Up 58.5% Over Last 7 Days
Etheroll Trading Up 58.5% Over Last 7 Days
Contrasting TransMontaigne  & Shell Midstream Partners
Contrasting TransMontaigne & Shell Midstream Partners
Analyzing Superior Uniform Group  & Lululemon Athletica
Analyzing Superior Uniform Group & Lululemon Athletica
Financial Contrast: Aaron’s  and Its Peers
Financial Contrast: Aaron’s and Its Peers
Emerge Energy Services  Receives $13.14 Consensus PT from Brokerages
Emerge Energy Services Receives $13.14 Consensus PT from Brokerages
Zacks: Analysts Anticipate Key Energy Services  to Announce -$1.24 Earnings Per Share
Zacks: Analysts Anticipate Key Energy Services to Announce -$1.24 Earnings Per Share


© 2006-2018 Ticker Report. Google+.